Literature DB >> 31879160

Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Carcinoma Using Radiomics Features Based on the Fat-Suppressed T2 Sequence.

Hongna Tan1, Fuwen Gan2, Yaping Wu1, Jing Zhou1, Jie Tian3, Yusong Lin2, Meiyun Wang4.   

Abstract

RATIONALE AND
OBJECTIVES: To investigate the value of radiomics method based on the fat-suppressed T2 sequence for preoperative predicting axillary lymph node (ALN) metastasis in breast carcinoma.
MATERIALS AND METHODS: The data of 329 invasive breast cancer patients were divided into the primary cohort (n = 269) and validation cohort (n = 60). Radiomics features were extracted from the fat-suppressed T2-weighted images on breast MRI, and ALN metastasis-related radiomics feature selection was performed using Mann-Whitney U-test and support vector machines with recursive feature elimination; then a radiomics signature was constructed by linear support vector machine. The predictive models were constructed using a linear regression model based on the clinicopathologic factors and radiomics signature, and nomogram was used for a visual prediction of the combined model. The predictive performances are evaluated with the sensitivity, specificity, accuracy, and area under the receiver operating characteristic curve.
RESULTS: A total of 647 radiomics features were extracted from each patient. About 23 ALN metastasis-related radiomics features were selected to construct the radiomics signature, including 17 texture features, 5 first-order statistical features, and one shape feature; patient age, tumor size, HER2 status, and vascular cancer thrombus accompanied or not were selected to construct the cilinicopathologic feature model. The sensitivity, specificity, accuracy, and are under the curve value of radiomics signature, clinicopathologic feature model, and the nomogram were 65.22%, 81.08%, 75.00%, and 0.819 (95% confidence interval [CI]: 0.776-0.861), 30.44%, 81.08%, 61.67%, and 0.605 (95% CI: 0.571-0.624) and 60.87%, 89.19%, 78.33%, and 0.810 (95% CI: 0.761-0.855), respectively.
CONCLUSION: Radiomics methods based on the fat-suppressed T2 sequence and the nomogram are helpful for preoperative accurate predicting ALN metastasis.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Axillary lymph node; Breast cancer; MRI; Metastasis; Radiomics

Mesh:

Year:  2019        PMID: 31879160     DOI: 10.1016/j.acra.2019.11.004

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  11 in total

Review 1.  Radiomics in breast MRI: current progress toward clinical application in the era of artificial intelligence.

Authors:  Hiroko Satake; Satoko Ishigaki; Rintaro Ito; Shinji Naganawa
Journal:  Radiol Med       Date:  2021-10-26       Impact factor: 3.469

2.  Prediction Breast Molecular Typing of Invasive Ductal Carcinoma Based on Dynamic Contrast Enhancement Magnetic Resonance Imaging Radiomics Characteristics: A Feasibility Study.

Authors:  Aqiao Xu; Xiufeng Chu; Shengjian Zhang; Jing Zheng; Dabao Shi; Shasha Lv; Feng Li; Xiaobo Weng
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

3.  Preoperative Nomogram for Predicting Sentinel Lymph Node Metastasis Risk in Breast Cancer: A Potential Application on Omitting Sentinel Lymph Node Biopsy.

Authors:  Xi'E Hu; Jingyi Xue; Shujia Peng; Ping Yang; Zhenyu Yang; Lin Yang; Yanming Dong; Lijuan Yuan; Ting Wang; Guoqiang Bao
Journal:  Front Oncol       Date:  2021-04-26       Impact factor: 6.244

4.  "Real-world" radiomics from multi-vendor MRI: an original retrospective study on the prediction of nodal status and disease survival in breast cancer, as an exemplar to promote discussion of the wider issues.

Authors:  Simon J Doran; Santosh Kumar; Matthew Orton; James d'Arcy; Fenna Kwaks; Elizabeth O'Flynn; Zaki Ahmed; Kate Downey; Mitch Dowsett; Nicholas Turner; Christina Messiou; Dow-Mu Koh
Journal:  Cancer Imaging       Date:  2021-05-20       Impact factor: 3.909

5.  A Clinical-Radiomics Model for Predicting Axillary Pathologic Complete Response in Breast Cancer With Axillary Lymph Node Metastases.

Authors:  Liangyu Gan; Mingming Ma; Yinhua Liu; Qian Liu; Ling Xin; Yuanjia Cheng; Ling Xu; Naishan Qin; Yuan Jiang; Xiaodong Zhang; Xiaoying Wang; Jingming Ye
Journal:  Front Oncol       Date:  2021-12-21       Impact factor: 6.244

6.  Prediction of Metastasis in the Axillary Lymph Nodes of Patients With Breast Cancer: A Radiomics Method Based on Contrast-Enhanced Computed Tomography.

Authors:  Chunmei Yang; Jing Dong; Ziyi Liu; Qingxi Guo; Yue Nie; Deqing Huang; Na Qin; Jian Shu
Journal:  Front Oncol       Date:  2021-09-20       Impact factor: 6.244

7.  Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma.

Authors:  Aqiao Xu; Xiufeng Chu; Shengjian Zhang; Jing Zheng; Dabao Shi; Shasha Lv; Feng Li; Xiaobo Weng
Journal:  BMC Cancer       Date:  2022-08-10       Impact factor: 4.638

8.  Clinical-radiomics nomogram for identifying HER2 status in patients with breast cancer: A multicenter study.

Authors:  Caiyun Fang; Juntao Zhang; Jizhen Li; Hui Shang; Kejian Li; Tianyu Jiao; Di Yin; Fuyan Li; Yi Cui; Qingshi Zeng
Journal:  Front Oncol       Date:  2022-09-07       Impact factor: 5.738

Review 9.  Beyond N Staging in Breast Cancer: Importance of MRI and Ultrasound-based Imaging.

Authors:  Valerio Di Paola; Giorgio Mazzotta; Vincenza Pignatelli; Enida Bufi; Anna D'Angelo; Marco Conti; Camilla Panico; Vincenzo Fiorentino; Francesco Pierconti; Fleur Kilburn-Toppin; Paolo Belli; Riccardo Manfredi
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

10.  Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Based on Intratumoral and Peritumoral DCE-MRI Radiomics Nomogram.

Authors:  Ying Liu; Xing Li; Lina Zhu; Zhiwei Zhao; Tuan Wang; Xi Zhang; Bing Cai; Li Li; Mingrui Ma; Xiaojian Ma; Jie Ming
Journal:  Contrast Media Mol Imaging       Date:  2022-08-18       Impact factor: 3.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.